Free Trial

Glanbia Plc ADR (OTCMKTS:GLAPY) Short Interest Update

Glanbia logo with Consumer Staples background

Key Points

  • Glanbia Plc ADR (OTCMKTS:GLAPY) experienced a significant decline in short interest, dropping to just 100 shares as of August 31st, a decrease of 50.0% from earlier in the month.
  • The company's stock traded down 1.5% to $79.41, with a trading volume of 105 shares compared to an average of 16 shares.
  • Glanbia has announced a dividend of $0.9751 to be paid on October 14th, resulting in a yield of 272.0%.
  • Interested in Glanbia? Here are five stocks we like better.

Glanbia Plc ADR (OTCMKTS:GLAPY - Get Free Report) saw a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 100 shares, a decrease of 50.0% from the August 15th total of 200 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.0% of the company's shares are short sold. Approximately 0.0% of the company's shares are short sold. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 1.0 days.

Glanbia Price Performance

Shares of GLAPY remained flat at $79.41 during trading hours on Friday. Glanbia has a twelve month low of $52.40 and a twelve month high of $83.00. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.67 and a quick ratio of 0.89. The firm's 50-day simple moving average is $76.55 and its 200-day simple moving average is $69.91.

Glanbia Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Tuesday, October 14th. Stockholders of record on Tuesday, August 26th will be given a dividend of $0.9751 per share. The ex-dividend date is Monday, August 25th. This represents a dividend yield of 272.0%.

About Glanbia

(Get Free Report)

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.

Further Reading

Should You Invest $1,000 in Glanbia Right Now?

Before you consider Glanbia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.

While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.